Drug Profile
Pamidronic acid
Alternative Names: AHPrBP; Amino hydroxypropylidene diphosphonic acid; Aminomux; APD; Aredia; CGP 23339A; CGP 23339AE; Disodium aminohydroxypropylidenediphosphonate; Disodium pamidronate; IG 7913; Pamidronate sodium; PanorinLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Gador; Henkel
- Developer Andromaco; Drogueria Marco-Med; Gador Paraguay; Hanlim Pharmaceutical; Leti; MAC Laboratories; Nippon Kayaku; Novartis; Raices; Seignior Pharma; Sued Farmaceutica
- Class Antihypercalcaemics; Bisphosphonates; Calcium regulators; Osteoporosis therapies; Small molecules
- Mechanism of Action Bone resorption factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Cancer metastases; Malignant hypercalcaemia; Osteitis deformans; Osteogenesis imperfecta; Osteoporosis; Postmenopausal osteoporosis
- No development reported Bone cancer; Cancer pain